Arvee Laboratories (India) Ltd Share Price

Chemicals - Speciality - Medium / SmallNSE
₹168.34
-6.05-3.47% (1D)
As on 21 Aug 2026 at 05:53
As of 21 Aug 2026 at 05:53, Arvee Laboratories (India) Ltd is trading at ₹168.34, with a market cap of ₹185.51 crore. At a P/E of 45.74 and a dividend yield of 0.00%, it is a small-cap stock in the Chemicals sector.

ARVEE Price Chart

Market Cap
₹185.51 Cr
PE Ratio
45.74
ROCE
7.57%

Arvee Laboratories (India) Ltd Performance

Arvee Laboratories (India) Ltd Fundamentals

Market Cap₹185.51 Cr
ROE7.48%
P/E Ratio (TTM)45.74
EPS (TTM)₹3.68
P/B Ratio5.49
Dividend Yield0.00%
Industry P/E103.49
Book Value₹30.66
Debt to Equity0.03
Face Value₹10

Arvee Laboratories (India) Ltd Shareholding Pattern

Promoter73.5%
Foreign Institutions0%
Mutual Funds0%
Domestic Institutions0%
Public26.5%

Arvee Laboratories (India) Ltd Financial Statements

No data for this view.

Arvee Laboratories (India) Ltd Peer Comparison

StocksLTP(₹)Market Cap(Cr)52 Week Low-High(₹)
SRF Ltd
₹2,570.50
-8.10(-0.31%)
76,196.02,355.0 - 3,210.0
Linde India Ltd
₹6,694.42
-8.08(-0.12%)
57,092.8
Godrej Industries Ltd
₹1,226.50
8.50(+0.70%)
41,314.8
Himadri Speciality Chemical Ltd
₹703.65
-46.60(-6.21%)
35,504.4
Deepak Nitrite Ltd
₹1,749.95
-18.35(-1.04%)
23,868.1

About Arvee Laboratories (India)

Arvee Laboratories (India) Limited was incorporated as a Private Limited Company with the name 'Arvee Laboratories (India) Private Limited' on January 27, 2012 in Ahmedabad, Gujarat. Subsequently, the Company name was changed to Arvee Laboratories (India) Limited on September 19, 2017. Presently, Company is engaged in manufacturing of specialized chemicals. Since, April 01, 2013 the control & management was completely taken over by Mr. Shalin Sudhakarbhai Patel and Mr. Shalin Bharat Chokshi. The Company started construction of its first plant for Thiophene Derivatives in 2013. It acquired land, building and machineries from Skylink Chemicals Private Limited and started manufacturing unit. It commissioned the Thiophene Derivatives Plant in 2013. In 2014, the Company started construction of plant for Sulfo and Nitro Derivatives of Isophthalic Acid. In 2015, it commissioned the plant for Nitro Derivatives of Isophthalic Acid. In February 2018, the Company came up with a Public Issue of 14,60,000 Equity Shares by raising money through equity aggregating Rs 8.90 Crore. The vision of promoters, Mr. Shalin Bharat Chokshi and Mr. Shalin Sudhakarbhai Patel aims at diversifying the activity of manufacturing specialty chemicals like Dimethyl 5-Nitroisphthalate, 2-ThiopheneCarboxaldehyde, 2-Acetyl Thiophene, Lithium Sulpho Isopthalic Acid-LiSIPA, etc that cater to the needs and demands of other businesses in India and overseas. The diversification into other chemicals are based on the yield that a particular chemical is providing by leading to low wastage and high effectiveness. The plant facilities and other utility services at Arvee are equipped to undertake a host of processes namely: Nitration, Sulfonation, Reduction, Esterification, Hoffman Reaction, Caustic Fusion, etc.

Parent Organisation
Founded2012
Managing DirectorShalin Sudhakarbhai Patel
NSE SymbolARVEE

Arvee Laboratories (India) Ltd Resistance and Support levels

R3190.53R2185.30R1182.06S1171.60S2168.36S3163.13168.34

Arvee Laboratories (India) Ltd Technicals

Current Price
₹168.34 ₹6.05 (-3.47%)
Bearish
2
Bullish
10
  • 20 Day2.2%
  • 50 Day3.4%
  • 100 Day3.2%
  • 200 Day2.1%

Arvee Laboratories (India) Ltd Latest News

View More
04 MAY 2026 | Monday
Arvee Laboratories (India) schedules board meeting

2026

Board MeetingAnnounced
Board MeetingAnnounced
Board MeetingAnnounced

Frequently asked questions

The share price of Arvee Laboratories (India) Ltd is ₹168.34 as of 21 Aug 2026 at 05:53.

Not sure where to start?

Book a free 30-minute consultation with our investment experts today!

Invest Now